BeOne Medicines Raises FY2026 Sales Guidance from $6.300B-$6.500B to $6.600B-$6.800B vs $6.479B Est

Benzinga Newsdesk www.benzinga.com Positive 93.4%

Neg 0% Neu 0% Pos 93.4%

BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.300 billion-$6.500 billion to $6.600 billion-$6.800 billion vs $6.479 billion estimate.